{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-087276","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.402859+00:00","generated_at":"2026-05-31T15:53:23.628817+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Aspira Women's Health appoints John Ragard to Board of Directors","bullets":["John Ragard appointed to board effective July 25, 2024; designated by stockholder Jack W. Schuler.","Ragard brings over 46 years of venture capital and public equity investment experience.","Currently Senior Investment Advisor at Wayve Capital; previously managed portfolios at Spouting Rock and Friess Associates.","Will serve as director until the company's 2025 annual meeting of stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-087276","json":"https://secwatch.observer/filing/0000950170-24-087276.json","markdown":"https://secwatch.observer/filing/0000950170-24-087276.md","text":"https://secwatch.observer/filing/0000950170-24-087276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/0000950170-24-087276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/awh-20240725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:53:23.628817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e27a74fc3","claim":"John Ragard was appointed as director at Aspira Women's Health Inc..","evidence_excerpt":"On July 29, 2024, Aspira Women’s Health Inc. (the “Company”) issued a press release announcing the appointment of John Ragard as a director, effective July 25, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024087276/0000950170-24-087276-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}